Please assess the completion status of the following clinical trial:

Trial Title: Vitamin Deficiencies and Suppletion in Morbid Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Vitamin B12 deficiency: \<200 pmol/l~* Vitamin B12 deficiency 6-12 months after surgery~* All patients underwent a Roux-en-Y gastric bypass~Exclusion Criteria:~1. Creatin \>150micromol/L~2. Liver enzymes \>2 times upper limit~3. Other bariatric operations~4. Intercurrent diseases~5. Gastro-intestinal diseases~6. Psychiatric disease~7. Medicines which influences bone density~8. Pregnancy

- Gender: MALE
- Minimum Age: 18 Months
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- hydroxocobalamin injection (Type: ACTIVE_COMPARATOR): 25 patients receive the standard treatment of a vitamin B12 deficiency: hydroxocobalamin injection
- FitForMe vitamin B12 tablets (Type: ACTIVE_COMPARATOR): 25 patients receive a daily dose vitamine B12 tablets

Based on this trial design, predict the completion outcome and termination type (if applicable).